Ken Griffin Care Dx, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$7.56 - $16.15 $15,876 - $33,915	2,100 Added 26.58%	10,000 $155,000
Q1 2024 May 15, 2024	BUY	$7.96 - $12.37 $42,984 - $66,798	5,400 Added 216.0%	7,900 $83,000
Q4 2023 Feb 14, 2024	SELL	$4.9 - $12.86 $13,230 - $34,722	-2,700 Reduced 51.92%	2,500 $30,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $11.26 $42,700 - $68,686	-6,100 Reduced 53.98%	5,200 $36,000
Q2 2023 Aug 14, 2023	SELL	$7.61 - $9.46 $34,245 - $42,570	-4,500 Reduced 28.48%	11,300 $96,000
Q1 2023 May 15, 2023	SELL	$8.83 - $17.61 $108,609 - $216,603	-12,300 Reduced 43.77%	15,800 $144,000
Q4 2022 Feb 14, 2023	BUY	$10.88 - $20.05 $305,728 - $563,405	28,100 New	28,100 $320,000

170

48.6M

60.8K

34.9K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.24B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.